A 79-year-old man with known heart failure with reduced ejection fraction (HFrEF) is on ramipril, bisoprolol, and furosemide. He remains symptomatic (...

Question

A 79-year-old man with known heart failure with reduced ejection fraction (HFrEF) is on ramipril, bisoprolol, and furosemide. He remains symptomatic (NYHA II-III) with NT-proBNP elevated and eGFR 68. Which additional disease-modifying therapy is recommended?

Accepted Answer

Add spironolactone

Answer

Add verapamil

Answer

Add diltiazem

Answer

Switch ramipril to amlodipine

Answer

Add doxazosin

ukmla MCQ (SBA): HFrEF optimisation

A 79-year-old man with known heart failure with reduced ejection fraction (HFrEF) is on ramipril, bisoprolol, and furosemide. He remains symptomatic (NYHA II-III) with NT-proBNP elevated and eGFR 68. Which additional disease-modifying therapy is recommended?